-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Enzon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Enzon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $254K, a 20.9% decline year-over-year.
- Enzon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $1.52M, a 47.2% increase year-over-year.
- Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $1.37M.
- Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$186K, a 60.3% increase from 2021.
- Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$469K, a 64.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)